KURA Kura Oncology Inc
Company Analysis
Latest News
Kura Oncology Earns Zacks Upgrade, Driven by KOMZIFTI Commercial Rollout
Zacks Investment Research upgraded Kura Oncology, Inc. to a Rank #2 (Buy) on September 2, 2026. Rising earnings estimates prompted the positive shift in...
Connor Clark & Lunn Buys $11M Kura Oncology Stake, Citing KOMZIFTI Sales
Connor Clark & Lunn Investment Management Ltd. opened a new position in Kura Oncology, Inc. during the second quarter. The firm purchased 996,114 shares. This...
🟢 Kura Oncology is trading 10.4% up today after CEO purchased $1.24 million in shares
Kura Oncology is trading at $13.69, up +10.40%, after President and CEO Troy Wilson purchased 100,000 shares for approximately $1.24 million on August 24,...
🟢 Kura Oncology is trading 8.47% up today after CEO bought 100,000 shares
Kura Oncology is trading 8.47% up now at $13.45 after President and CEO Troy Wilson purchased 100,000 shares for approximately $1.24 million on August 24,...
Kura Oncology's CEO Keeps Buying Stock With His Own Money — Is He Seeing Something Wall Street Hasn't Priced In?
Shares of Kura Oncology surged 11.3% to $13.80 after a regulatory filing revealed President and CEO Troy Wilson scooped up another 100,000 shares for roughly...
🟢 Kura Oncology is trading 11.29% up in pre-market after CEO discloses another 100,000-share purchase
Kura Oncology is trading 11.29% up in pre-market at $13.80 after President and CEO Troy Wilson disclosed another purchase of 100,000 shares on August 24,...
🟢 Kura Oncology is trading 6.1% up in pre-market after CEO buys another 100,000 shares
Kura Oncology is trading 6.13% up now at $13.16 after President and CEO Troy Wilson disclosed a second 100,000-share purchase. - The August 24, 2026 purchase...